Global Blood Therapeutics
Why Robinhood?
You can watch GBT and buy or sell other stocks, ETFs, and their options commission-free!About GBT
Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases.
GBT Key Statistics
Stock Snapshot
The current Global Blood Therapeutics(GBT) stock price is $68.49, with a market capitalization of 4.62B. The stock trades at a price-to-earnings (P/E) ratio of -13.70.
Global Blood Therapeutics(GBT) stock opened on 2026-05-13 at —. The price climbed to — and dipped to —.
Global Blood Therapeutics(GBT) shares are trading with a volume of 0, against a daily average of 2.06M.
During the past year, Global Blood Therapeutics(GBT) stock moved between $21.65 at its lowest and $73.02 at its peak.
During the past year, Global Blood Therapeutics(GBT) stock moved between $21.65 at its lowest and $73.02 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.